ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-pxvi.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-pxvi.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-pxxxiv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-pxxxiv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p939.xmlChest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p939.pdf2026-04-18Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndromehttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p932.xmlTen Years of Progress in Melanoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p932.pdf2026-04-18Ten Years of Progress in Melanomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p919.xmlA Partnership Between the Academic and the Community2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p919.pdf2026-04-18A Partnership Between the Academic and the Communityhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p926.xmlRandomized Controlled Trials and 21st Century Epistemology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p926.pdf2026-04-18Randomized Controlled Trials and 21st Century Epistemologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p969.xmlInfluential Factors for Post-Fellowship Career Decision-Making: An NCCN Survey2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p969.pdf2026-04-18Influential Factors for Post-Fellowship Career Decision-Making: An NCCN Surveyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p961.xmlCurrent Approaches in Hereditary Nonpolyposis Colorectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p961.pdf2026-04-18Current Approaches in Hereditary Nonpolyposis Colorectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p951.xmlSoft Tissue Sarcoma, Version 2.20122026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p951.pdf2026-04-18Soft Tissue Sarcoma, Version 2.2012https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p947.xmlThe First Documented Case of High-Grade Synovial Cell Sarcoma of the Rectum2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p947.pdf2026-04-18The First Documented Case of High-Grade Synovial Cell Sarcoma of the Rectumhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p984.xmlAcute Myeloid Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p984.pdf2026-04-18Acute Myeloid Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p975.xmlOptimal Management of Malignant Pleural Effusions (Results of CALGB 30102)2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p975.pdf2026-04-18Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p1037.xmlManaging the Financial Impact of Cancer Treatment: The Role of Clinical Practice Guidelines2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p1037.pdf2026-04-18Managing the Financial Impact of Cancer Treatment: The Role of Clinical Practice Guidelineshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p1029.xmlMonitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready for Prime Time?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p1029.pdf2026-04-18Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready for Prime Time?https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p1023.xmlWho Benefits From Maintenance Therapy in Acute Promyelocytic Leukemia?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/8/article-p1023.pdf2026-04-18Who Benefits From Maintenance Therapy in Acute Promyelocytic Leukemia?